ALS Limited shares (ASX:ALQ) have surged to a new all-time high, reaching a peak of A$19.03, marking a 24.75% increase year-to-date. In closing Wednesday’s session at A$18.90, ALQ has been a strong outperformer on the year.
Supporting a move higher was ALS’ recently reported first-half FY25 results, giving bulls further momentum. This financial strength is coupled with strategic expansions in the Life Sciences division, particularly in Europe and the USA, aimed at diversifying service offerings and strengthening market presence.
“Our strategic initiatives are designed to strengthen our market position and deliver sustainable growth,” stated an ALS Limited spokesperson in a recent press release regarding their European expansion.
Looking ahead, the market will be watching ALS Limited’s ability to sustain its growth momentum and capitalize on its strategic initiatives. The average price target of A$17.77 currently sits down from here, although many have cited the company’s diversified business model and strong financial position as key drivers for future success.
Don’t Buy Just Yet
You will want to see this before you make any decisions.
Top Australian Brokers
- Pepperstone - Top Australian broker - Read our review
- eToro - Invest in ASX and international shares - Read our review
Before you decide which shares to add to your portfolio you might want to take a look at this special report we recently published.
Our experts picked out The 5 best ASX shares to buy in 2025.
We’re giving away this valuable research for FREE.
Click below to secure your copy
